West Pharmaceutical Services Inc (WST) stock
WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3032% above fair value
$416.42+5.12 (+1.24%)
Close on Nov 13, 2026Market cap $29.01BP/E 46.7Yield 0.21%
West Pharmaceutical Services enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
West Pharmaceutical Services's enterprise value was $28.83B on Nov 11, 2026, against $19.51B a year earlier. Over the last 5 years it ranged from $14.94B to $34.32B, with a median of $22.93B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $28.83B | +49.0% |
| 2025 | Dec 31, 2025 | $19.36B | -17.5% |
| 2024 | Dec 31, 2024 | $23.46B | -7.5% |
| 2023 | Dec 29, 2023 | $25.37B | +50.1% |
| 2022 | Dec 30, 2022 | $16.90B | -50.8% |
| 2021 | Dec 31, 2021 | $34.32B | +66.0% |
| 2020 | Dec 31, 2020 | $20.67B | +89.3% |
| 2019 | Dec 31, 2019 | $10.92B | +52.5% |
| 2018 | Dec 31, 2018 | $7.16B | -1.8% |
| 2017 | Dec 29, 2017 | $7.29B | +17.0% |
| 2016 | Dec 30, 2016 | $6.23B | +42.1% |
| 2015 | Dec 31, 2015 | $4.39B | +13.0% |
| 2014 | Dec 31, 2014 | $3.88B | +8.1% |
| 2013 | Dec 31, 2013 | $3.59B | +61.3% |
| 2012 | Dec 31, 2012 | $2.23B | +39.9% |
| 2011 | Dec 30, 2011 | $1.59B | -10.5% |
| 2010 | Dec 31, 2010 | $1.78B | +34.0% |
| 2009 | Dec 31, 2009 | $1.33B | – |
See a number that looks wrong?